Time To Be Bold is a national public service awareness campaign helping the three million Americans 55 or older who are struggling with low vision regain their independence.

3D Human Tissue Retina Vasculature model provides a new and novel approach to rapidly and efficiently screening numerous therapies for diabetic retinopathy and diabetic macular edema.

Appointment reflects Glauconix Biosciences' expansion of their 3D Human Tissue model platform within the Ophthalmology space and brings their second commercial model closer to market

Appointment reflects Glauconix Biosciences' readiness to expand their commercial footprint and business verticals in the field of ophthalmology and beyond

Appointment reflects Glauconix Biosciences' commitment to business and organizational excellence as they continue on their trajectory to become the leading developer of ex vivo-like 3D human tissue models for accelerating therapeutic innovation and drug discovery

Appointment reflects Glauconix Biosciences' stage of high growth and innovation in the field of ophthalmology

Study confirms intraocular pressure-lowering effects of cannabinoid-based therapeutic, proving promising novel treatment for glaucoma

Dr Somdutt Prasad, one of the best retinal specialists, spoke on Diabetic Retinopathy at the event.

The two-day event will be held at The Eye Foundation in Coimbatore.

Sonoma County's award-winning Petaluma acupuncturist, David Russell, L.Ac, announces new specialized acupuncture treatments for degenerative vision loss

Barbara Wirostko, Senior Medical Director, Team Lead Ophthalmology, Pfizer will give a presentation at GTCbio's 2nd Annual Ocular Disease Drug & Discovery Conference, May 27 - 28, 2010 in Boston, MA.